{"name":"Arafat Tfayli","slug":"arafat-tfayli","ticker":"","exchange":"","domain":"","description":"Arafat Tfayli is a biotech company focused on the development of innovative therapies. The company's lead candidate, Compound 121564, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1FWS1MMkViTkxsNmg3ckhUdXRrVEdXUkhBRVk3QnlUeTJqcGxmbWFTQm9URjZIUVBqVnF6TzdEM3liOW82NDBEZGdaTEpJS0ZQZHVCak41S3VIb2tmWEVOWUFqNDNfQ1FKWDZRakdHeGZpQXNuVFVBejJkOA?oc=5","date":"2024-11-18","type":"pipeline","source":"Wiley","summary":"Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low-income countries - Wiley","headline":"Global disparities in cancer care: Bridging the gap in affordability and access to medications between high and low-inco","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}